Colchicine and Major Adverse Cardiovascular Events in Patients With Established Coronary or Cerebrovascular Atherosclerotic Disease: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Ahmed Alameleman Edris Ebrahim, Shaza Bakri Osman Elsayed, Nour Omera, Amal Hassan Sidahmed Ali, Areij Awad Osman Mohamed, Dalia Salih Mohammed Salih, Nibras Elfatih Hussein Abdalla, Esra Eltahir Mohamed Gamareldin · 2026
Read Colchicine and Major Adverse Cardiovascular Events in Patients With Established Coronary or Cerebrovascular Atherosclerotic Disease: A Systematic Review and Meta-Analysis of Randomised Controlled Trials by Ahmed Alameleman Edris Ebrahim, Shaza Bakri Osman Elsayed, Nour Omera, Amal Hassan Sidahmed Ali, Areij Awad Osman Mohamed, Dalia Salih Mohammed Salih, Nibras Elfatih Hussein Abdalla, Esra Eltahir Mohamed Gamareldin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13570228.txt.
Description
A peer-reviewed research article from Europe PMC (2026). Colchicine entered secondary-prevention guidelines on the strength of early randomised trials, but three large trials reported since 2024 have been neutral. We quantified its effect on major adverse cardiovascular events (MACE) and explored potential sources of heterogeneity between trials.We searched PubMed/MEDLINE, Embase, Cochrane CENTRAL, Scopus, and trial registries to 30 June 2026 for randomised trials of oral colchicine versus placebo or usual care in adults with established coronary or cerebrovascular atherosclerotic disease, requiring at least three months of planned treatment and a
Catalog record
| CREATOR | Ahmed Alameleman Edris Ebrahim, Shaza Bakri Osman Elsayed, Nour Omera, Amal Hassan Sidahmed Ali, Areij Awad Osman Mohamed, Dalia Salih Mohammed Salih, Nibras Elfatih Hussein Abdalla, Esra Eltahir Mohamed Gamareldin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |